BridgeBio Pharma, Inc.
BBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001743881
In the last 90 days, BridgeBio Pharma, Inc. insiders filed 0 open-market purchases and 5 sales; 475 institutions reported holding it in 13F filings for Q2 2026, worth $14.4B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q4 2023
Institutional positions in BridgeBio Pharma, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 247
- +27 vs. Q3 2023
- Shares held
- 165.7M
- +4.61M (+2.9%) vs. Q3 2023
- Total value
- $6.69B
- +$2.45B (+57.7%) vs. Q3 2023
- New holders
- 53
- 88 more added
- Sold out
- 26
- 77 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 475 | $14.4B |
| Q1 2026 | 462 | $14.4B |
| Q4 2025 | 435 | $14.4B |
| Q3 2025 | 392 | $9.62B |
| Q2 2025 | 359 | $8.15B |
| Q1 2025 | 304 | $6.45B |
| Q4 2024 | 263 | $4.85B |
| Q3 2024 | 254 | $4.39B |
| Q2 2024 | 251 | $4.43B |
| Q1 2024 | 244 | $5.31B |
| Q4 2023 | 247 | $6.69B |
| Q3 2023 | 221 | $4.24B |
| Q2 2023 | 197 | $2.58B |
| Q1 2023 | 213 | $2.53B |
| Q4 2022 | 179 | $1.10B |
| Q3 2022 | 181 | $1.44B |
| Q2 2022 | 165 | $1.28B |
| Q1 2022 | 179 | $1.45B |
| Q4 2021 | 195 | $2.37B |
| Q3 2021 | 212 | $6.56B |
| Q2 2021 | 201 | $8.70B |
| Q1 2021 | 199 | $8.69B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding BridgeBio Pharma, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 473,126 | $19.1M | 5.22% | 00.0% | Unchanged |
| Emerald Mutual Fund Advisers Trust | 500,254 | $20.2M | 1.07% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 544,019 | $22.0M | 0.00% | +80,242+17.3% | Added |
| Price T Rowe Associates Inc | 658,362 | $26.6M | 0.00% | +596,386+962.3% | Added |
| UBS Asset Management Americas Inc | 660,218 | $26.7M | 0.01% | −35,415−5.1% | Reduced |
| Citadel Advisors LLC | 664,155 | $26.8M | 0.03% | +95,495+16.8% | Added |
| Emerald Advisers, LLC | 685,539 | $27.7M | 1.18% | −8,461−1.2% | Reduced |
| Octagon Capital Advisors LP | 706,800 | $28.5M | 4.57% | −264,839−27.3% | Reduced |
| Eventide Asset Management, LLC | 716,927 | $28.9M | 0.47% | 00.0% | Unchanged |
| Barclays PLC | 742,038 | $30.0M | 0.02% | +260,598+54.1% | Added |
| Manufacturers Life Insurance Company, The | 744,132 | $30.0M | 0.02% | +78,528+11.8% | Added |
| Ensign Peak Advisors, Inc | 745,071 | $30.1M | 0.06% | +112,361+17.8% | Added |
| Altitude Crest Partners Inc. | 754,560 | $30.5M | 20.38% | +754,560 | New |
| D. E. Shaw & Co., Inc. | 924,865 | $37.3M | 0.05% | −416,378−31.0% | Reduced |
| Principal Financial Group Inc | 943,484 | $38.1M | 0.02% | +197,818+26.5% | Added |
| Primecap Management Co | 944,000 | $38.1M | 0.03% | +5,300+0.6% | Added |
| Two Sigma Investments, LP | 966,797 | $39.0M | 0.09% | −310,287−24.3% | Reduced |
| UBS Group AG | 985,510 | $39.8M | 0.02% | +832,940+545.9% | Added |
| Capital Research Global Investors | 1,100,110 | $44.4M | 0.01% | 00.0% | Unchanged |
| Voloridge Investment Management, LLC | 1,105,989 | $44.6M | 0.18% | −143,669−11.5% | Reduced |
| Charles Schwab Investment Management Inc | 1,123,220 | $45.3M | 0.01% | +66,945+6.3% | Added |
| Janus Henderson Group PLC | 1,143,563 | $46.2M | 0.03% | −500.0% | Reduced |
| Northern Trust Corp | 1,154,972 | $46.6M | 0.01% | +1,057+0.1% | Added |
| Norges Bank | 1,160,342 | $46.8M | 0.01% | +664,254+133.9% | Added |
| Invesco Ltd. | 1,272,536 | $51.4M | 0.01% | +112,383+9.7% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 1,391,240 | $56.2M | 1.13% | −1,391,510−50.0% | Reduced |
| T. Rowe Price Investment Management, Inc. | 1,435,280 | $57.9M | 0.04% | +439,648+44.2% | Added |
| Wellington Management Group LLP | 1,495,114 | $60.4M | 0.01% | +75,564+5.3% | Added |
| Citigroup Inc | 1,557,231 | $62.9M | 0.08% | −30,361−1.9% | Reduced |
| Morgan Stanley | 1,659,782 | $67.0M | 0.01% | +211,722+14.6% | Added |
| Perceptive Advisors LLC | 1,748,933 | $70.6M | 1.58% | 00.0% | Unchanged |
| SC US (TTGP), Ltd. | 1,860,364 | $75.1M | 0.62% | 00.0% | Unchanged |
| FMR LLC | 2,414,341 | $97.5M | 0.01% | −13,181−0.5% | Reduced |
| Alliancebernstein L.P. | 2,557,416 | $103.2M | 0.04% | −158,724−5.8% | Reduced |
| Geode Capital Management, LLC | 2,714,168 | $109.6M | 0.01% | +202,988+8.1% | Added |
| Frazier Life Sciences Management, L.P. | 2,725,949 | $110.0M | 5.88% | 00.0% | Unchanged |
| Pictet Asset Management Holding SA | 2,767,185 | $111.7M | 0.12% | +27,163+1.0% | Added |
| Lord, Abbett & Co. LLC | 3,098,082 | $125.1M | 0.44% | +2,303,681+290.0% | Added |
| Goldman Sachs Group Inc | 3,266,635 | $131.9M | 0.03% | +1,841,478+129.2% | Added |
| Cormorant Asset Management, LP | 3,344,179 | $135.0M | 6.46% | −1,318,351−28.3% | Reduced |
| State Street Corp | 5,086,899 | $205.4M | 0.01% | +46,485+0.9% | Added |
| Laurion Capital Management LP | 5,241,833 | $211.6M | 7.59% | −409,206−7.2% | Reduced |
| Aisling Capital Management LP | 6,068,125 | $245.0M | 73.07% | 00.0% | Unchanged |
| BlackRock Inc. | 10,156,773 | $410.0M | 0.01% | +906,830+9.8% | Added |
| Vanguard Group Inc | 12,800,294 | $516.7M | 0.01% | +1,524,313+13.5% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 25,120,991 | $1.01B | 3.71% | 00.0% | Unchanged |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $1.25B | 37.06% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −584,146−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −275,000−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −107,409−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −90,600−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −86,071−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −81,150−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −63,978−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −51,872−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −48,540−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −37,211−100.0% | Sold out |
| Clearline Capital LP | 0 | $0 | 0.00% | −32,394−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −31,800−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −16,482−100.0% | Sold out |
| Pinnacle Associates Ltd | 0 | $0 | 0.00% | −14,750−100.0% | Sold out |
| Pinnacle Wealth Management Advisory Group, LLC | 0 | $0 | 0.00% | −14,750−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −14,468−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −9,216−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −8,711−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −7,843−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −5,265−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Hexagon Capital Partners LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Steward Financial Group LLC | – | – | – | – | Not filed |